The preliminary prospectus supplement and the accompanying base shelf prospectus are available for free on the SEC website atwww.sec.gov. Alternatively, the documents may be obtained by contacting Barclays Capital Inc. toll free at1-888-603-5847, Goldman Sachs & Co. LLC, Prospectus Department toll free at1-866-471-2526 or bye-mailingProspectus-ny@ny.email.gs.com, Morgan Stanley & Co. LLC toll free at1-866-718-1649 or RBC Capital Markets, LLC toll-free at1-866-375-6829.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the senior notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
Forward-Looking Statements
Certain statements and other information included in this press release constitute “forward-looking information” within the meaning of applicable Canadian securities legislation or constitute “forward-looking statements” within the meaning of applicable U.S. securities legislation (together, “forward-looking statements”). All statements in this press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to, forecasts and statements as to management’s expectations with respect to, among other things, the intended use of proceeds of the offering and the timing of closing of the offering. Such forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond our control, as well as various assumptions and business sensitivities, including those risk factors referred to in the preliminary prospectus supplement referenced in this press release and those referred to under the heading “Risk Factors” in Nutrien’s annual information form for the year ended December 31, 2018 and under the heading “Enterprise Risk Management” in management’s discussion and analysis for the year ended December 31, 2018, which may cause actual results, performance or achievements of Nutrien, which includes the offering being delayed or not completed, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable U.S. federal securities law. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and perception of historical trends, current conditions and expected future developments as well as other factors we believe are appropriate in the circumstances. All of the forward-looking statements contained herein are qualified by these cautionary statements and by the assumptions that are stated or inherent in such forward-looking statements. Although we believe these assumptions are reasonable, undue reliance should not be placed on these assumptions and such forward-looking statements.
FOR FURTHER INFORMATION:
Investor and Media Relations:
Richard Downey
Vice President, Investor & Corporate Relations
(403)225-7357
Investor Relations:
Jeff Holzman
Senior Director, Investor Relations
(306)933-8545
Todd Coakwell
Director, Investor Relations
(403)225-7437
Contact us at: www.nutrien.com
2